Equities

Celsius Holdings Inc

CELH*:MEX

Celsius Holdings Inc

Actions
  • Price (MXN)606.00
  • Today's Change1.00 / 0.17%
  • Shares traded3.17k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 25 2024 20:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.

  • Revenue in USD (TTM)1.37bn
  • Net income in USD170.09m
  • Incorporated2005
  • Employees765.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CELH:NAQ since
announced
Transaction
value
Big Beverages Contract Manufacturing LLCDeal completed01 Nov 202401 Nov 2024Deal completed-1.10%75.00m
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.